Written question asked by Philip Davies (Conservative) on Tuesday, 17 April 2007, in the House of Commons. It was due for an answer on Thursday, 19 April 2007. It was answered by Ivan Lewis (Labour) on Thursday, 3 May 2007 on behalf of the Department of Health.
Healthcare: Acquired Infections
- Question
- To ask the Secretary of State for Health what assessment she has made of the effectiveness of STERIS Vaporized Hydrogen Peroxide technology in tackling MRSA within the NHS.
- Answer
-
The Rapid Review Panel has reviewed Steris’ vaporised hydrogen peroxide and awarded it a recommendation 2 stating that basic research and development has been completed and the product may have potential value; in use evaluations/trials are now needed in an national health service clinical setting.The Department is currently funding a project to evaluate environmental cleaning for methicillin-resistant Staphylococcus aureus. As part of this Steris’ vaporised hydrogen peroxide equipment will be evaluated alongside wet disinfection in both a hospital side room and a controlled exposure chamber.
Secondary information
- Type
- Written question
- Reference
- 132968; 459 c1843-4W
- Session
- 2006-07
- Subjects
- Hospitals MRSA Cleaning services Hydrogen peroxide
- Link
- View this Written question on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2021-07-22 21:04:11 +0100
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1228151
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1228151
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1228151